Global

‡ In these countries please contact our distributor

ACTICOAT Flex

ACTICOAT* Flex

 

 

ACTICOAT* Flex has been designed to offer a highly conformable interface between the site of injury and secondary dressing. Protection is also provided through sustained antimicrobial performance.

ACTICOAT Flex
  • Maintains contact with the wound bed even in awkward anatomical areas.
  • Kills pathogenic organisms common to wounds in order to reduce the risk of infection. 1
  • Provides comfort for the patient during wear and allows them to move with the dressing still in place. 6
  • May be used to complement negative pressure wound therapy protocols. 3

 


 

Evidence

ACTICOAT Flex

1. ACTICOAT* Flex is soft and highly flexible with stretch properties

  • Moves with the patient when they need to move the affected body part. 6
  • Minimises discomfort for the patient.
  • Can be removed without causing trauma to the wound bed 4.

 

 

2. ACTICOAT* Flex allows fluid transport into the secondary dressing to minimise the risk of maceration. 5

 

ACTICOAT Flex

Demand Absorbency

 

Absorbency (g) ACTICOAT Flex - Demand absorbency

Time (s)

 

 

  EXU-DRY*   EXU-DRY + ACTICOAT   EXU-DRY   EXU-DRY +
ACTICOAT Flex 7

 

 

3. ACTICOAT* Flex Provides sustained (3 or 7 day) antimicrobial activity against a broad spectrum of wound pathogens including MRSA & Pseudomonas aeruginosa 1


Removes the barrier to healing thus allowing the patient to regain control and progress the wound to healing.

 

Mean
log
reduction
(log10
cfu/
sample)

Antimicrobial activity measured by log reduction of ACTICOAT Flex 7 against common pathogenic wound pathogens over a 24 hour period
  0hr   4hr   24hr

 

Figure 1. Antimicrobial activity measured by log reduction of ACTICOAT Flex 7 against common pathogenic wound pathogens over a 24 hour period (mean results, n= 3)

 

4. ACTICOAT* Flex Rapidly kills bacteria in as little as thirty minutes 2.

Antibacterial action helps provide rapid protection from bacterial colonisation and aids in the prevention of resistance.

 

Mean
log
reduction
(log10
cfu/
sample)

6.0

 

 

5.0

 

 

4.0

 

 

3.0

 

 

2.0

 

 

0.0

 

 

 

Batch 081024-1
Batch 081026-2

ACTICOAT* Flex 3
Batch 081214-1
 

 

  S. aureus   P. aeruginosa

 

 

Figure 2. Antimicrobial activity measured by log reduction of ACTICOAT Flex 3 against S. aureus and P. aeruginosa at 30 minutes (mean results, n=3)

 

 


 

Available with either 7 day or 3 day wear time

ACTICOAT* Flex is available with either 7 day (ACTICOAT Flex 7) or 3 day (ACTICOAT Flex 3) wear time.

 

There is a range of sizes to suit a range of indications.

 


Ordering codes

Catalogue# Size Box quantity
ACTICOAT Flex 3    
66800396 5cm x 5cm 5
66800398 10cm x 10cm 5
66800399 10cm x 10cm 12
66800409 10cm x 20cm 12
66800419 20cm x 40cm 6
66800432 40cm x 40cm 6
66800435 10cm x 120cm 6
ACTICOAT Flex 7    
66800545 2.5cm x 60cm 5
66800395 5cm x 5cm 5
66800397 10cm x 12.5cm 5
66800420 15cm x 15cm 5
66800400 20cm x 40cm 6
66800401 40cm x 40cm 6

 

 


 

References

1. Smith and Nephew Data on Files ref. 0901003. Antimicrobial activity of ACTICOAT Flex 7 against pathogenic
wound pathogens. (In-vitro data)
2. Smith and Nephew Data on File ref. 0810018. ACTICOAT Flex 3 has antimicrobial activity in 30 minutes. (In-vitro data)
3. Smith and Nephew Data on File ref. 0810015. To show efficacy of ACTICOAT Flex in combination with NPWT (In-vitro data)
4. Smith and Nephew expert statement. ACTICOAT wound bed preparation and wound trauma.
5. Smith and Nephew Data on File ref 0809009, Demand absorbency.
6. Smith and Nephew report ref. DS.08.123.R1